14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation
暂无分享,去创建一个
S. Varambally | Arindam Ghosh | S. Bae | S. Sudarshan | M. Ballestas | S. Shelar | J. Mobley | Suman Karki | A. Kundu | Hyeyoung Nam | Garrett J. Brinkley | Richard Kirkman
[1] J. Cheville,et al. Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma , 2019, The Journal of clinical investigation.
[2] Zhongming Zhao,et al. TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer , 2019, Cell Research.
[3] Fei Lan,et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer , 2018, Nature.
[4] Yuanyuan Zhou,et al. Restoration of 5‐hydroxymethylcytosine by ascorbate blocks kidney tumour growth , 2018, EMBO reports.
[5] O. Abdel-Wahab,et al. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression , 2017, Cell.
[6] Yi Zhang,et al. TET-mediated active DNA demethylation: mechanism, function and beyond , 2017, Nature Reviews Genetics.
[7] Wenbing Xie,et al. Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress. , 2017, Molecular cell.
[8] S. Chanock,et al. TET2 binds the androgen receptor and loss is associated with prostate cancer , 2016, Oncogene.
[9] G. Barton,et al. 14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides , 2015, Bioinform..
[10] J. Nickels,et al. Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d* , 2015, The Journal of Biological Chemistry.
[11] Yi Zhang,et al. Regulation of TET protein stability by calpains. , 2014, Cell reports.
[12] Ze Li,et al. Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation , 2013, Cell.
[13] S. Batra,et al. Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. , 2013, Cancer letters.
[14] M. Skwarczynska,et al. Activation of NF-κB signalling by fusicoccin-induced dimerization , 2012, Proceedings of the National Academy of Sciences.
[15] J. Soulier,et al. Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.
[16] C. Cheng,et al. 14-3-3 and its binding partners are regulators of protein-protein interactions during spermatogenesis. , 2009, The Journal of endocrinology.
[17] A. Hagemeijer,et al. Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.
[18] K. Pfizenmaier,et al. Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III β protects from dephosphorylation and stabilizes lipid kinase activity , 2006, Journal of Cell Science.
[19] Michael D. George,et al. Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. , 2005, Cancer research.
[20] C. MacKintosh,et al. Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.
[21] Michael Levin,et al. Fusicoccin signaling reveals 14-3-3 protein function as a novel step in left-right patterning during amphibian embryogenesis , 2003, Development.
[22] Michael B. Yaffe,et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport , 2002, The Journal of cell biology.
[23] S. Masters,et al. 14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.
[24] E Ruoslahti,et al. Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. , 1999, Biochemistry.
[25] James M. Roberts,et al. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. , 1996, Genes & development.
[26] P. Allen,et al. Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.